Biotech · Private company · Princeton, NJ, US
Zena Therapeutics Inc.
Track this companyFree. Adds Zena Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Development of compound RUEC2-118, a novel partial GABAAR positive modulator, a fast-acting treatment for general anxiety and panic disorder, to prevent opioid and benzodiazepine overdose fatalities.Fiscal year 2024 · $55KNIH RePORTER 3R41DA058472-01S1 · fetched Nov 12, 2026